Bridging the Gap: Jasmine Jones on Empowering Racially and Ethnically Diverse Communities Through Research

Choose the health content that’s right for you, and get it delivered right in your inbox.

In a time when health disparities still impact access and outcomes for many, Jasmine Jones is working to ensure that underrepresented populations are not left behind. As the Diversity, Equity, and Inclusion Program Manager at AdventHealths Translational Research Institute, she plays a critical role in connecting racially and ethnically diverse communities throughout Central Florida with research opportunities—especially in areas like diabetes, where early detection and ongoing management are essential. Her focus isn't just about data or participation—it’s about trust, education, and empowerment.

“My role is to raise awareness about research,” Jones explains. “That starts with simply letting people know we exist and what we do. It includes talking through fears and concerns, especially historical ones, and helping people see research as an added care option—not something to be afraid of.”

Q&A with Jasmine Jones

Q: What are some common concerns you hear when talking to people about participating in clinical trials?
A: The classic one is, “I don’t want to be a guinea pig,” or “What are they going to do with my blood or DNA?” Another big one is historical mistrust, particularly among African American communities. People are cautious because of past abuses in research.

Q: How do you respond to those concerns?
A: I start by acknowledging that history and then explain how things have changed. We now have institutional review boards, FDA guidelines, and ethical standards that protect participants. I emphasize that participation is voluntary, and I encourage people to ask as many questions as they want. It’s about empowering them with information.

Q: In terms of diabetes research, how important is it for people to have access to a research institute like TRI in their own community?
A: It's hugely beneficial. We have so many people in our community living with Type 1 and Type 2 diabetes. When they learn that we’re doing research right here in their backyard, they’re drawn to it. They want to understand their condition better and access new care options. We frame clinical trials as a pathway to more personalized, potentially beneficial care.

Culturally Relevant Outreach

Jones says that reaching racially and ethnically diverse communities requires more than just good intentions—it takes intentional, thoughtful action.

We’re working to make sure our materials are available in languages commonly spoken in the community—like Spanish and Haitian Creole—and that our staff reflect the people we serve,” she says.

Cultural and language barriers can complicate access to care and information. By adapting their outreach strategies, the AdventHealth Translational Research Institute is creating more inclusive spaces for learning and engagement.

Reaching People Where They Are

One of the most successful initiatives Jasmine highlighted involved simple diabetes screenings offered in partnership with a community organization focused on men’s health. Participants received their A1C and blood pressure readings on the spot, which prompted many to schedule follow-up visits with their doctors.

“Men aren’t always proactive about their health, so making it easy and accessible was key,” Jones notes.

They’ve also collaborated with the National Kidney Foundation and hosted educational seminars on topics like healthy aging, obesity, and exercise, featuring principal investigators from TRI. These events open the door to meaningful conversations between community members and researchers.

A Surprising Response

While many assume underrepresented communities are resistant to research, Jasmine says her experience has been the opposite.

“People are curious. They want to improve their health. They want to be part of the conversation. When we talk about research as a care option that might help them or someone in their family, they listen—and they ask great questions,” she says.

A Final Message

When asked what she wants people to know about clinical trials, Jones says it comes down to two things:

“It’s an added care option—and it’s a way to contribute to science for future generations. Your participation could change lives.”

Recent Blogs

Blog
She Deserves a Legacy: $30k for Oncology Nurses
Blog
God's Provision: Jimmy's Story
Blog
AHU Alumni Highlight | John Itoe
Blog
Celebrating Generosity: An Evening Propelled With Purpose
Blog
Volunteer of the Month | Dena Jalbert
View More Articles